Publication:
Reply to: "The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD".

dc.contributor.authorAmpuero, Javier
dc.contributor.authorGallego-Durán, Rocío
dc.contributor.authorRomero-Gómez, Manuel
dc.date.accessioned2023-02-09T10:38:40Z
dc.date.available2023-02-09T10:38:40Z
dc.date.issued2020-12-24
dc.identifier.doi10.1016/j.jhep.2020.12.020
dc.identifier.essn1600-0641
dc.identifier.pmid33359898
dc.identifier.unpaywallURLhttp://www.journal-of-hepatology.eu/article/S0168827820338952/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16846
dc.issue.number4
dc.journal.titleJournal of hepatology
dc.journal.titleabbreviationJ Hepatol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number971-972
dc.pubmedtypeLetter
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshFibrosis
dc.subject.meshHumans
dc.subject.meshLiver Cirrhosis
dc.subject.meshNon-alcoholic Fatty Liver Disease
dc.titleReply to: "The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD".
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number74
dspace.entity.typePublication

Files